
|Articles|July 1, 2004
Pimecrolimus improves quality of life, lowers use of medical resources for AD
Washington -A Canadian study of 515 patients with atopic dermatitis showed that treatment with Elidel cream significantly reduced patients' use of medical resources over the six-month study period and had a positive impact on the quality of life of atopic dermatitis patients in all age groups examined.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
2
Dual-Action Microneedle Patch Shows Promise for Psoriasis in Preclinical Study
3
AI Analysis Reveals Menopausal Hair Loss Linked to Systemic Health and Inflammation
4
Health Canada Grants Priority Review to Birch Triterpenes for EB
5














